IL234116B - A preparation with sialidase activity for the treatment of parainfluenza virus in patients with a deficiency in the immune system - Google Patents

A preparation with sialidase activity for the treatment of parainfluenza virus in patients with a deficiency in the immune system

Info

Publication number
IL234116B
IL234116B IL234116A IL23411614A IL234116B IL 234116 B IL234116 B IL 234116B IL 234116 A IL234116 A IL 234116A IL 23411614 A IL23411614 A IL 23411614A IL 234116 B IL234116 B IL 234116B
Authority
IL
Israel
Prior art keywords
treatment
composition
parainfluenza virus
sialidase activity
immunocomprimised
Prior art date
Application number
IL234116A
Other languages
English (en)
Hebrew (he)
Original Assignee
Ansun Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ansun Biopharma Inc filed Critical Ansun Biopharma Inc
Publication of IL234116B publication Critical patent/IL234116B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01018—Exo-alpha-sialidase (3.2.1.18), i.e. trans-sialidase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL234116A 2012-02-17 2014-08-13 A preparation with sialidase activity for the treatment of parainfluenza virus in patients with a deficiency in the immune system IL234116B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261600545P 2012-02-17 2012-02-17
US201261727627P 2012-11-16 2012-11-16
PCT/US2013/026754 WO2013123521A1 (en) 2012-02-17 2013-02-19 Methods, Compounds and Compositions for Treatment of Parainfluenza Virus in Immunocompromised Patients

Publications (1)

Publication Number Publication Date
IL234116B true IL234116B (en) 2020-03-31

Family

ID=48984833

Family Applications (2)

Application Number Title Priority Date Filing Date
IL234116A IL234116B (en) 2012-02-17 2014-08-13 A preparation with sialidase activity for the treatment of parainfluenza virus in patients with a deficiency in the immune system
IL273194A IL273194B2 (en) 2012-02-17 2020-03-10 Methods, compounds and compositions for treatment of parainfluenza virus in immunocompromised patients

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL273194A IL273194B2 (en) 2012-02-17 2020-03-10 Methods, compounds and compositions for treatment of parainfluenza virus in immunocompromised patients

Country Status (9)

Country Link
US (4) US20130280332A1 (enExample)
EP (1) EP2841092B1 (enExample)
JP (1) JP2015508780A (enExample)
CN (2) CN109529026A (enExample)
AU (3) AU2013221230A1 (enExample)
CA (1) CA2864746A1 (enExample)
ES (1) ES2970401T3 (enExample)
IL (2) IL234116B (enExample)
WO (1) WO2013123521A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2799403C (en) 2010-05-14 2020-01-21 Dana-Farber Cancer Institute, Inc. Compositions and methods for treating leukemia
WO2011143657A1 (en) 2010-05-14 2011-11-17 Dana-Farber Cancer Institute, Inc. Male contraceptive compositions and methods of use
HUE031073T2 (en) 2010-05-14 2017-06-28 Dana Farber Cancer Inst Inc Thieno triazolo-diazepine compounds for the treatment of neoplasia
KR20160034379A (ko) 2013-07-25 2016-03-29 다나-파버 캔서 인스티튜트 인크. 전사 인자의 억제제 및 그의 용도
RU2016122654A (ru) 2013-11-08 2017-12-14 Дана-Фарбер Кэнсер Инститьют, Инк. Комбинированная терапия злокачественной опухоли с использованием ингибиторов бромодоменового и экстратерминального (вет) белка
US10150756B2 (en) 2014-01-31 2018-12-11 Dana-Farber Cancer Institute, Inc. Diaminopyrimidine benzenesulfone derivatives and uses thereof
US10793571B2 (en) 2014-01-31 2020-10-06 Dana-Farber Cancer Institute, Inc. Uses of diazepane derivatives
CA2940472A1 (en) 2014-02-28 2015-09-03 Tensha Therapeutics, Inc. Treatment of conditions associated with hyperinsulinaemia
RU2017104897A (ru) 2014-08-08 2018-09-10 Дана-Фарбер Кэнсер Инститьют, Инк. Производные диазепана и их применения
EP3177147A4 (en) 2014-08-08 2018-01-24 Dana-Farber Cancer Institute, Inc. Dihydropteridinone derivatives and uses thereof
EA033325B1 (ru) 2014-10-27 2019-09-30 Тэнша Терапеутикс, Инк. Ингибиторы бромодомена
WO2016073903A1 (en) * 2014-11-06 2016-05-12 Dana-Farber Cancer Institute, Inc. Use of compositions modulating chromatin structure for graft versus host disease (gvhd)
WO2016073956A1 (en) 2014-11-06 2016-05-12 Dana-Farber Cancer Institute, Inc. Ezh2 inhibitors and uses thereof
WO2016200916A1 (en) * 2015-06-08 2016-12-15 Ansun Biopharma, Inc. Treatment of human metapneumovirus
CA2986441A1 (en) 2015-06-12 2016-12-15 Dana-Farber Cancer Institute, Inc. Combination therapy of transcription inhibitors and kinase inhibitors
KR20180051576A (ko) 2015-09-11 2018-05-16 다나-파버 캔서 인스티튜트 인크. 아세트아미드 티에노트리아졸로디아제핀 및 그의 용도
CN108472300A (zh) 2015-09-11 2018-08-31 达纳-法伯癌症研究所股份有限公司 氰基噻吩并三唑并二氮杂环庚三烯及其用途
PE20181298A1 (es) 2015-11-25 2018-08-07 Dana Farber Cancer Inst Inc Inhibidores de bromodominio bivalentes y usos de los mismos
CN109069508A (zh) 2016-04-22 2018-12-21 达纳-法伯癌症研究所股份有限公司 Ezh2抑制剂及其用途
JP2023502776A (ja) * 2019-11-25 2023-01-25 アンサン バイオファーマ， インク． 癌細胞、免疫細胞および腫瘍微小環境へのシアリダーゼの免疫細胞送達

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7334580B2 (en) * 2002-05-07 2008-02-26 Smaldone Gerald C Methods, devices and formulations for targeted endobronchial therapy
EP1539284B1 (en) * 2002-09-06 2020-01-29 Philip Morris Products S.a.s. Aerosol generating device and method for generating aerosols
US7807174B2 (en) * 2002-11-22 2010-10-05 Nexbio, Inc. Class of therapeutic protein based molecules
US8084036B2 (en) 2002-11-22 2011-12-27 Nexbio, Inc. Broad spectrum anti-viral therapeutics and prophylaxis
US20070190163A1 (en) * 2006-01-24 2007-08-16 Malaknov Michael P Technology for preparation of macromolecular microspheres
CN102711807A (zh) * 2009-11-06 2012-10-03 耐百生物制药有限公司 用于在呼吸道中进行治疗和预防的方法、化合物和组合物

Also Published As

Publication number Publication date
CA2864746A1 (en) 2013-08-22
EP2841092A4 (en) 2015-09-16
AU2019226190B2 (en) 2021-10-07
US20150132274A1 (en) 2015-05-14
CN104203267A (zh) 2014-12-10
AU2017258955A1 (en) 2017-12-14
WO2013123521A1 (en) 2013-08-22
IL273194B2 (en) 2023-02-01
EP2841092B1 (en) 2023-12-06
EP2841092A1 (en) 2015-03-04
JP2015508780A (ja) 2015-03-23
EP2841092C0 (en) 2023-12-06
HK1207975A1 (en) 2016-02-19
ES2970401T3 (es) 2024-05-28
AU2019226190A1 (en) 2019-09-26
CN109529026A (zh) 2019-03-29
IL273194A (en) 2020-04-30
US20170151315A1 (en) 2017-06-01
US20210046165A1 (en) 2021-02-18
IL273194B (en) 2022-10-01
AU2013221230A1 (en) 2014-10-02
US20130280332A1 (en) 2013-10-24

Similar Documents

Publication Publication Date Title
IL234116B (en) A preparation with sialidase activity for the treatment of parainfluenza virus in patients with a deficiency in the immune system
IL249991A0 (en) Methods of treating sick children by dexmedetomidine
ZA201308417B (en) Tissue healing
IL234678A0 (en) Diagnostic methods and preparations for cancer treatment
EP2675478A4 (en) COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF GRIP
IL237568A0 (en) Assembly for the treatment of biological tissues
GB201202773D0 (en) Compositions for treatment of skin disorders
HUE038787T2 (hu) Tripeptid készítmények és alkalmazásuk diabétesz kezelésére
EP2797593A4 (en) SILICONE-BASED COMPOSITION FOR TREATING SKIN
IL234606A0 (en) Innovative methods and compounds for the treatment of diseases
IL232434A0 (en) Medicine for medical treatment and/or improvement of sepsis
EP2872087A4 (en) IMPROVED NON-SKINLESSING DISPOSABLE THREAD
GB201102248D0 (en) Treatment of bipolar disorder
ZA201307058B (en) Use of polyaminoisoprenyl derrivatives in antobiotic or antisertic treatment
ZA201408065B (en) Compositions and methods for the treatment of diabetes
SG11201504201RA (en) Purification of x-ray contrast agents
ZA201409502B (en) Composition for treatment of warts
GB201010638D0 (en) Composition for treatment of skin
PT2456445E (pt) Agente para o tratamento de condições da pele
HUP1100245A2 (en) Pharmaceutical composition for the treatment of wounds
GB201110653D0 (en) Composition for skin treatment
GB201110659D0 (en) composition for skin treatment
GB201208505D0 (en) Treatment of skin condition
GB201121044D0 (en) Treatment of solutions
GB201104632D0 (en) Use of medicament

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed